Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia

  • Stephen R. Marder
  • , Larry Alphs
  • , Ion George Anghelescu
  • , Celso Arango
  • , Thomas R.E. Barnes
  • , Ivo Caers
  • , David G. Daniel
  • , Eduardo Dunayevich
  • , W. Wolfgang Fleischhacker
  • , George Garibaldi
  • , Michael F. Green
  • , Philip D. Harvey
  • , René S. Kahn
  • , John M. Kane
  • , Richard S.E. Keefe
  • , Bruce Kinon
  • , Stefan Leucht
  • , Jean Pierre Lindenmayer
  • , Anil K. Malhotra
  • , Virginia Stauffer
  • Daniel Umbricht, Keith Wesnes, Shitij Kapur, Jonathan Rabinowitz

Research output: Contribution to journalReview articlepeer-review

52 Scopus citations

Fingerprint

Dive into the research topics of 'Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science